$2.29
8.03% yesterday
Nasdaq, Apr 03, 10:09 pm CET
ISIN
US1920051067
Symbol
CDXS

Codexis, Inc. Stock price

$2.29
-0.45 16.27% 1M
-0.81 26.13% 6M
-2.48 51.99% YTD
-1.05 31.44% 1Y
-19.59 89.53% 3Y
-7.51 76.63% 5Y
-2.36 50.75% 10Y
Nasdaq, Closing price Thu, Apr 03 2025
-0.20 8.03%
ISIN
US1920051067
Symbol
CDXS
Industry

Key metrics

Market capitalization $189.70m
Enterprise Value $175.64m
P/E (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 2.96
P/S ratio (TTM) P/S ratio 3.20
P/B ratio (TTM) P/B ratio 2.80
Revenue growth (TTM) Revenue growth -15.39%
Revenue (TTM) Revenue $59.35m
EBIT (operating result TTM) EBIT $-58.35m
Free Cash Flow (TTM) Free Cash Flow $-53.72m
Cash position $73.96m
EPS (TTM) EPS $-0.90
P/E forward negative
P/S forward 2.89
EV/Sales forward 2.68
Short interest 6.15%
Show more

Is Codexis, Inc. a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,794 stocks worldwide.

Codexis, Inc. Stock Analysis

Unlock Scores for Free

Analyst Opinions

7 Analysts have issued a Codexis, Inc. forecast:

5x Buy
71%
2x Hold
29%

Analyst Opinions

7 Analysts have issued a Codexis, Inc. forecast:

Buy
71%
Hold
29%

Financial data from Codexis, Inc.

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Dec '24
+/-
%
59 59
15% 15%
100%
- Direct Costs 21 21
15% 15%
36%
38 38
26% 26%
64%
- Selling and Administrative Expenses 46 46
22% 22%
78%
- Research and Development Expense 42 42
28% 28%
71%
-50 -50
12% 12%
-85%
- Depreciation and Amortization 8.13 8.13
18% 18%
14%
EBIT (Operating Income) EBIT -58 -58
6% 6%
-98%
Net Profit -65 -65
14% 14%
-110%

In millions USD.

Don't miss a Thing! We will send you all news about Codexis, Inc. directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Codexis, Inc. Stock News

Neutral
GlobeNewsWire
28 days ago
REDWOOD CITY, Calif., March 07, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the approval of equity grants to two new employees as approved by the Compensation Committee of Codexis' Board of Directors. The newly hired employees received equity awards consisting of an aggreg...
Neutral
Seeking Alpha
about one month ago
Codexis, Inc. (NASDAQ:CDXS ) Q4 2024 Earnings Conference Call February 27, 2025 4:30 PM ET Company Participants Carrie McKim - Director of Investor Relations Stephen Dilly - President and Chief Executive Officer Kevin Norrett - Chief Operating Officer Georgia Erbez - Chief Financial Officer Conference Call Participants Richard Miller - Cantor Fitzgerald, L.P. Matthew Stanton - Jefferies Group L...
Neutral
GlobeNewsWire
about 2 months ago
REDWOOD CITY, Calif., Feb. 14, 2025 (GLOBE NEWSWIRE) -- Codexis, Inc. (NASDAQ: CDXS), a leading provider of enzymatic solutions for efficient and scalable therapeutics manufacturing, today announced the approval of equity grants to five new employees as approved by the Compensation Committee of Codexis' Board of Directors. The newly hired employees received equity awards consisting of an aggreg...
More Codexis, Inc. News

Company Profile

Codexis, Inc. engages in the discovery, development, and sale of proteins. The company offers enzyme optimization services and developing biocatalyst products. The firm operates through the following segments: Performance Enzymes and Novel Biotherapeutics. Its technologies accelerate the development of manufacturing processes for active pharmaceutical ingredients fine chemicals, agrochemicals, food ingredients, detergents and biofuels. The company was founded in January 2002 and is headquartered in Redwood City, CA.

Head office United States
CEO Stephen Dilly
Employees 188
Founded 2002
Website www.codexis.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today